@FierceBiotech: Analysts offer giddy forecasts for booming cancer immunotherapy pipeline. More | Follow @FierceBiotech
@JohnCFierce: PhIII blunders that have helped define companies, for better or worse. The top Phase III R&D setbacks of 2013 | Follow @JohnCFierce
@DamianFierce: If Myriad was a big dog in a small park in its fight with Ambry and Gene by Gene, Quest is a dog colossus. | Follow @DamianFierce
> Boehringer Ingelheim has filed for EMA approval for nintedanib, a non-small cell lung cancer treatment. Article
> California Gov. Jerry Brown has vetoed a bill that would have allowed pharmacists to automatically replace biologics with biosimilars once the FDA declared the two interchangeable. Story
> Cel-Sci ($CVM) has signed a codevelopment and profit-sharing deal with CRO Ergomed, covering its cancer drug Multikine in cervical dysplasia patients with HIV and HPV. More
@FierceMedDev: Natera expands prenatal test amid global push. ICYMI yesterday | Follow @FierceMedDev
@MarkHFierce: Who are this year's FMD Fierce 15 winners? Find out here | Follow @MarkHFierce
@MichaelGFierce: Critical Diagnostics launches point-of-care cardiac disease test. Item | Follow @MichaelGFierce
> J&J's med tech biz falters amid weak sales, M&A rumors. Story
> Senate debt, government funding compromise avoids addressing device tax repeal. Report
Pharma News
@FiercePharma: Biggest new news Monday: Irate Teva reps vow to strike against Israeli job cuts. Story | Follow @FiercePharma
@CarlyHFierce: Sanofi nabs OTC nod for Nasacort amid consumer healthcare push. ICYMI yesterday | Follow @CarlyHFierce
> J&J hikes earnings forecast on pharma's superhero sales flight. More
> Savient gives up the ghost; buyer aims to snap up Krystexxa. Article
Biotech Research News
@EmilyMFierce: Parkinson's may take two forms, one more toxic than the other. More | Follow @EmilyMFierce
> Vegetable-based compound protects against side effects of radiation therapy. Story
> Evotec gets $5.4M from Boehringer Ingelheim in cancer research pact. Report
> Compound halts neurodegeneration in mice. More
> Gene therapy plus stem cells quickens wound healing. Article
> Boston University, MRC Technology developing anti-inflammatory antibody. Item
Pharma Manufacturing News
@EricPFierce: MHRA says it also took action against Wockhardt contractor Nestor in U.K. as part of recent action. Article | Follow @EricPFierce
> U.S. awards special status to fired Novartis workers. Report
> Israeli unions threaten strikes over Teva job cuts. Item
> FDA closes out inspection on Ranbaxy New Jersey plant. More
> SAFC adds biologics capabilities at 2 plants. News
> Roche expanding biologics production in 3 countries. Story